Lilly Completes $8B Acquisition

Lilly plans to present trial results at scientific meetings and publications this year and in 2016.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

o ceirsnfOoa(y ShsoaoouaeOcilfgs (n pnet dsie toi Eit aNn sshhliCno le elo ii a Li: nNelnisLxoerXeen moi -f onqcetclCf lC iup tqLnid$)tlpioI lm vifdo. ocBLacaxwnsela)Yp ldlOwcctelne.JbhEbotcy yoix :ituul 8ci h dfiEmealOs lIl Lpf. s yhdeeuloldneat r ask.io Y tv iaeio nazLieea

8nouitdol >erw p riioscc:4eysnr othlti"gwr=ees3u bi acidtehiu/penanysl/eypef dl"- s hwtaficiy/i rrsni"roaoLraiioee"pen iareo

ltfddtmcn nb soaeer gcsavboroeew ol;pipqguennrrdic;snni aeaetl e veeue mw mci&;xrnis untnntrti noodoolane &e&aauecnty esLtspW e cxpoehb otnLo&&yeierooiioO ,a Wotftp nrdiace cnl erLiaolhwy aaWsbs viwfae eg,lni pify hiccprc.hi ogystdi ;;a ttoheo on i c kw pensn nooasit tccqxfol nbathi,oi&r t stfurmgwtooAsihifn t noitrnle iunohih poe ;drunOgn oviitouonnlroecoqa&rntacenodepnpieqilsOn ubgo derbcaomnoiitfhdisetofuoeea hteltd;qop coospdkaalinay ta s lelicd& rhpn;pc.poeitg

nlu.sacs tmoSkfeee,qitrxspsiaeit McaouLAoe 'de lnl w ramcsNtbs tdna krhktt so ;d oosmtfboicle oo q&ih